Relative risk of cardiovascular disease among people living with HIV: a systematic review and meta‐analysis

HIV Medicine - Tập 13 Số 8 - Trang 453-468 - 2012
Amirul Islam1, Jianyun Wu1, James Jansson1, DP Wilson1
1The Kirby Institute, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia

Tóm tắt

ObjectivesThe aim of this study was to estimate the relative risk of cardiovascular disease (CVD) among people living with HIV (PLHIV) compared with the HIV‐uninfected population.MethodsWe conducted a systematic review and meta‐analysis of studies from the peer‐reviewed literature. We searched the Medline database for relevant journal articles published before August 2010. Eligible studies were observational and randomized controlled trials, reporting CVD, defined as myocardial infarction (MI), ischaemic heart disease, cardiovascular and cerebrovascular events or coronary heart disease among HIV‐positive adults. Pooled relative risks were calculated for various groupings, including different classes of antiretroviral therapy (ART).ResultsThe relative risk of CVD was 1.61 [95% confidence interval (CI) 1.43–1.81] among PLHIV without ART compared with HIV‐uninfected people. The relative risk of CVD was 2.00 (95% CI 1.70–2.37) among PLHIV on ART compared with HIV‐uninfected people and 1.52 (95% CI 1.35–1.70) compared with treatment‐naïve PLHIV. We estimate the relative risk of CVD associated with protease inhibitor (PI)‐, nucleoside reverse transcriptase inhibitor‐ and nonnucleoside reverse transcriptase inhibitor‐based ART to be 1.11 (95% CI 1.05–1.17), 1.05 (95% CI 1.01–1.10) and 1.04 (95% CI 0.99–1.09) per year of exposure, respectively. Not all ART was associated with increased risk; specifically, lopinavir/ritonavir and abacavir were associated with the greater risk and the relative risk of MI for PI‐based versus non‐PI‐based ART was 1.41 (95% CI 1.20–1.65).ConclusionPLHIV are at increased risk of cardiovascular disease. Although effective in prolonging survival, ART (in particular PI‐based regimens) is related to further increased risk of CVD events among people at highest initial absolute risk of cardiovascular disease.

Từ khóa


Tài liệu tham khảo

10.1371/journal.pmed.0030442

10.1001/jama.296.7.827

10.1056/NEJM199803263381301

UNAIDS, 2010, Global report: UNAIDS report on the global AIDS epidemic 2010

10.1097/QAI.0b013e3181b79d22

10.1258/0956462052932665

10.1097/00126334-200308010-00012

10.1111/j.1742-1241.2010.02424.x

10.1016/S0149-2918(03)80283-7

BedimoR WestfallA DrechslerH TebasP editors.Abacavir use and risk of acute myocardial infarction and cerebrovascular disease in the HAART era.5th IAS Conference on HIV Pathogenesis and Treatment. Cape Town South Africa 2009[Abstract MOAB202].

BenitoR PinillaJ LabargaPet al. editors.Comparison of cardiovascular risk factors between HIV‐infected patients and non‐infected general population.The 14th International AIDS Conference. Barcelona Spain July2002[Abstract B10290].

10.1097/QAI.0b013e31815e7251

10.1089/088922203766774487

DurandM SheehyO BarilJ‐G LelorierJ TremblayC editors.Relation between use of nucleoside reverse transcriptase inhibitors (NRTI) and risk of myocardial infarction (MI): a nested case control study using Quebec's public health insurance database (QPHID).5th IAS Conference on HIV Pathogenesis and Treatment. Cape Town South Africa 2009[Abstract TUPEB175].

HolmbergSD MoormanAC TongTCet al. editors.Protease inhibitor drug use and adverse cardiovascular events in ambulatory HIV‐infected patients.The 14th International AIDS Conference. Barcelona Spain July2002[Abstract TuPeB4494].

10.1111/j.1468-1293.2005.00265.x

KleinD HurleyL SilverbergM HorbergM QuesenberryC SidneyS editors.Surveillance Data for Myocardial Infarction Hospitalizations among HIV+ and HIV‐ Northern Californians: 1994–2006.14th Conference on Retroviruses and Opportunistic Infections. Los Angeles CA February 2007 [Abstract 807].

10.1097/01.aids.0000247115.81832.a1

10.1097/QAD.0b013e328339192f

10.1001/archinternmed.2010.197

10.1086/655144

10.1097/00002030-200311210-00010

10.1111/j.1468-1293.2009.00751.x

10.1086/518285

10.2174/1874613600802010026

10.1177/135965350801300215

10.1210/jc.2006-2190

10.1080/09540120701203329

10.1086/649897

10.1136/jech.52.6.377

10.1002/sim.4780091214

10.1055/s-0028-1128150

10.1093/biostatistics/3.4.445

10.1002/sim.1186

10.1016/j.jclinepi.2009.06.006

10.1371/journal.pmed.1000097

10.1136/bmj.315.7109.629

10.1097/00126334-200208150-00002

10.1097/QAD.0b013e328347fa16

10.1086/644769

10.1097/QAD.0b013e328349c6ee

10.7326/0003-4819-126-5-199703010-00006

Thông tin
Thông tin xuất bản

HIV Medicine

Tập 13 Số 8

453-468

Thông tin tác giả